「Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model」の関連論文
-
A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis
-
Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non-small cell lung cancer
-
HER2 標的抗体薬物複合体、トラスツズマブデルクステカン(T-DXd)の免疫系への作用に関する解析
-
Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD-L1 expression
-
CD244陽性多形核細胞系骨髄由来抑制細胞は大腸癌マウスモデルにおいて腹膜播種の病態を反映する
-
癌性腹膜炎を伴う進行卵巣癌に対する新規治療戦略
-
The regenerative effect of portal vein injection of liver organoids by retrorsine/partial hepatectomy in rats
-
The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma
-
Circadian rhythm affects the magnitude of contact hypersensitivity response in mice
-
羊膜上皮細胞移植における門脈内投与の有効性および移植後凝固系活性化の評価
-
Establishment of Human Leukocyte Antigen-Mismatched Immune Responses after Transplantation of Human Liver Bud in Humanized Mouse Models
-
Elucidation of functional roles of CAMK2G in myelofibrosis.
-
Innovative Therapeutic Strategy Using Prostaglandin I2 Agonist (ONO1301) Combined with Nano Drug Delivery System For Pulmonary Arterial Hypertension
-
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation
-
Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones
-
Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen specific T cells
-
アメロジェニンはマクロファージにおけるCIITAのプロモーターIV領域のユークロマチン化を阻害しIFNγ誘導性のMHCクラスⅡ抗原提示を抑制する。
-
Wnt経路を標的とした悪性骨腫瘍の病態解析とスクレロスチンによる治療の臨床応用
-
Multilineage-differentiating stress enduring (Muse) 細胞による自己免疫性心筋炎モデルラットに対する細胞治療効果の検討
-
Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor
-
Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for ovarian endometriosis
-
Susceptibility of pancreatic cancer stem cells to reprogramming
-
Analysis of radiotherapy-induced alterations of CD8+ T cells and PD-L1 expression in patients with uterine cervical squamous cell carcinoma
-
Near Infrared Photoimmunotherapy Targeting DLL3 For Small Cell Lung Cancer
-
The pathology of PD-1 signal blockade-induced psoriasis-like dermatitis
-
A novel treatment with stem cells from human exfoliated deciduous teeth for hypoxic-ischemic encephalopathy in neonatal rats
-
大腸炎惹起性CD4+ T細胞における活性イオウの機能解明
-
非小細胞肺癌におけるB7-1およびPD-1/PD-L1免疫チェックポイント分子の発現と転移巣での変化
-
Low level of stromal lectin-like oxidized LDL receptor 1 and CD8+ cytotoxic T lymphocytes indicate poor prognosis of colorectal cancer
-
A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice
-
ヒトiPS細胞由来心筋細胞移植後の不整脈抑制方法の開発
-
Mitomycin C treatment improves pancreatic islet graft longevity in intraportal islet transplantation by suppressing proinflammatory response
-
Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
-
Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
-
シングルセルトランスクリプトーム解析を用いた食道扁平上皮癌内の腫瘍浸潤Bリンパ球における化学療法後の機能変化の解明
-
卵巣癌における糖転移酵素C2GnT1発現と機能の解析
-
High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors
-
CARD9の肺腺がんの新しい予後因子としての可能性
-
膵癌間質における酸化ストレス応答機構の解析
-
Dynamics of effector and naïve Regulatory T cells throughout pregnancy
-
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft‑versus‑host disease after bone marrow transplantation
-
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma
-
甲状腺未分化癌に対する新規治療法としてのIRAK1/4 Inhibitor I/lenvatinib併用療法の前臨床研究
-
初発・再発膠芽腫組織を使用した腫瘍微小環境の変化の解析とテモゾロミド耐性TS細胞に対する抗PD-L1抗体+M2マクロファージ阻害剤併用療法の検討
-
ヒト膵島移植における分離後膵島のβ細胞評価
-
末梢血単核球由来 Nrf2 発現量を指標としたがん治療への臨床応用に関する研究
-
膵がん細胞表面糖鎖を標的とした治療法の開発-レクチンを用いた光線療法-
-
トリプルネガティブ乳癌におけるグルココルチコイド作用の臨床病理学的意義;アンドロゲンシグナルとの相互作用
-
腎癌のメタボローム解析によるバイオマーカーの確立とチロシンキナーゼ阻害薬耐性獲得機構の解明